steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in hiv-infected ugandan adults稳态生物等效性的通用和创新者配方司他夫定、拉米夫定、奈韦拉平在感染艾滋病毒的乌干达的成年人.pdfVIP

  • 0
  • 0
  • 约4.97万字
  • 约 6页
  • 2017-10-13 发布于上海
  • 举报

steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in hiv-infected ugandan adults稳态生物等效性的通用和创新者配方司他夫定、拉米夫定、奈韦拉平在感染艾滋病毒的乌干达的成年人.pdf

steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in hiv-infected ugandan adults稳态生物等效性的通用和创新者配方司他夫定、拉米夫定、奈韦拉平在感染艾滋病毒的乌干达的成年人

Steady State Bioequivalence of Generic and Innovator Formulations of Stavudine, Lamivudine, and Nevirapine in HIV-Infected Ugandan Adults 1 2 3 4 5 Jayne Byakika-Tusiime , Leslie W. Chinn , Jessica H. Oyugi , Celestino Obua , David R. Bangsberg , Deanna L. Kroetz2* 1 Division of Epidemiology, School of Public Health, University of California Berkeley, Berkeley, California, United States of America, 2 Department of Biopharmaceutical Scienc

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档